GI & Endoscopy

Here are the five most read gastroenterology/endoscopy stories from April 3 to April 9, 2017.

Michael Bass, MD, is a gastroenterologist with the Newark-based GI Specialists of Delaware.

Memphis, Tenn.-based Baptist Memorial Health Care selected Weston, Fla.-based gMed's, a Modernizing Medicine company, gGastro electronic health record system and its gInsignts performance measure platform as its primary procedure report writer.

Here are six gastroenterologists making headlines the week of March 27, 2017.

Houston-based Rice University synthetic biologists developed ingestible gut bacteria capable of sensing colitis in mice.

Tel-Aviv, Israel-based RedHill Biopharma entered into a licensing agreement with Carcy, N.C.-based Entera Hill for its EnteraGam.

The American Gastroenterology Association issued best practices on long term proton pump inhibitor use.

A study published in The American Journal of Gastroenterology examined cholecystectomy's effectiveness in preventing recurrent pancreatitis.

Senior Vice President and General Manager of Bridgewater, N.J.-based Salix Pharmaceuticals Mark McKenna is dedicated to revolutionizing gastroenterology and preventing GI diseases.

Mark Lowe, MD, is a gastroenterologist and the vice chair of clinical affairs and strategic planning at Washington University School of Medicine at St. Louis.